Nigeria to Receive MenFive Vaccine for Meningitis Outbreaks
Nigeria is set to receive the groundbreaking MenFive vaccine, making it the first country to combat meningitis outbreaks with this new vaccine. The MenFive vaccine, developed through a 13-year collaboration between PATH and the Serum Institute of India, with support from the UK Government, targets five main strains of meningococcal meningitis, including the elusive serogroup X. The vaccine shows promise in addressing the current meningococcus C outbreak in Nigeria, offering vital protection against a range of meningitis strains prevalent in Africa. GAVI, the Global Alliance for Vaccines and Immunizations, highlights the significance of innovations like MenFive in combating infectious diseases…
